<div id="readability-page-1">04:41 PM EST, 12/04/2025 (MT Newswires) -- Capricor Therapeutics ( CAPR ) said late Thursday it has launched a proposed underwritten public offering of its common stock.The company said underwriters will have a 30-day option to buy up to 15% additional shares. Terms and size of the offering remain subject to market conditions.Capricor said proceeds will support the development and manufacturing of its product candidates, as well as general corporate purposes.Shares of the company were up 2.6% in after-hours activity. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

Capricor治療

東部標準時間 2025 年 12 月 4 日下午 4:41（MT Newswires）-- Capricor Therapeutics（CAPR）週四晚間表示，已啓動一項擬議的承銷公開發行普通股。該公司表示，承銷商將有 30 天的選擇權，可以購買最多 15% 的額外股份。發行的條款和規模仍然取決於市場條件。Capricor 表示，所得款項將用於支持其產品候選的開發和生產，以及一般企業用途。該公司的股票在盤後交易中上漲了 2.6%。MT Newswires 不提供投資建議。未經授權的複製是嚴格禁止的

Capricor 治療公司啓動了擬議的公開股票發行